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ABSTRACT This study compared the effect of intraventricular administration of
dopamine D1 or D2 agonists or of ACTH on the sequential stereotypy of a serial pattern
of grooming movements (“syntactic chain”). In a previous study, we showed that periph-
eral administration of D1 agonists increased the probability of occurrence and enhanced
the stereotypy of the already-stereotyped movement pattern. Here we made microinjec-
tions of either SKF 38393 (a partial D1 agonist; 5, 10, 15, 20, 40 mg), SKF 82958 (a full
D1 agonist; 5, 10, 20 mg), quinpirole (a D2 agonist; 5, 10, 20 mg), or ACTH-(1-24) (2, 5,
10 mg) into the lateral ventricles of rats. We measured the amount of grooming, the
relative probability that the complex sequence pattern would occur, and the degree to
which the syntactic pattern was completed faithfully. The total amount of grooming
behavior was increased by intraventricular SKF 82958 and by ACTH, but was not
changed by SKF 38393 and was decreased by quinpirole. Super-stereotypy of the
sequential pattern was produced only by dopamine D1 agonists. The relative probability
of initiating the syntactical sequence was increased by both SKF 38393 and SKF 82958,
but was reduced by quinpirole and ACTH. The full D1 agonist, SKF 82958, also
increased the likelihood that the pattern would be completed, thus causing sequential
super-stereotypy in the strongest sense. Our results highlight a role for dopamine D1
receptors, probably within the basal ganglia, in the production of sequential super-
stereotypy of complex behavioral patterns. Synapse 37:205–215, 2000.
© 2000 Wiley-Liss, Inc.
INTRODUCTION
Peripheral administration of dopamine D1 agonists
elicits grooming and increases the relative probability
and stereotypy of an already-stereotyped movement
pattern of grooming movements, called a “syntactic
chain” (Berridge and Aldridge, pages 194–204, this
issue). This stereotyped movement pattern occurs nat-
urally during grooming behavior emitted by rats, mice,
and other rodents (Berridge, 1990; Berridge et al.,
1987; Bolivar et al., 1996; Bursten et al., 1999). The
pattern organizes dozens of forepaw stroke and licking
movements into 4 sequential phases and depends on
dopamine projections to the striatum (Berridge et al.,
1987). The stereotyped sequence is essentially a fixed
action pattern: once a normal rat has emitted the first
few movements, the remaining phases will follow with
80 to 90% certainty (Berridge et al., 1987). Just as with
most fixed action patterns, however, it is not 100%
rigid, and that feature allows neural manipulations to
produce gradations in its stereotypy.
Sequential super-stereotypy of syntactic grooming
chains was revealed by 2 forms of pattern enhance-
ment after D1 agonists. First, there was an increase in
the relative probability that syntactic chains would be
initiated during grooming, making the pattern more
dominant in the overall flow of behavior. Second, the
pattern itself became more sequentially stereotyped, in
the sense that rats became even more likely to com-
plete it syntactically from beginning to end. When
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given systemically, both SKF 38393, a partial dopa-
mine D1 agonist, and SKF 82958, a full D1 agonist,
produced sequential super-stereotypy in the first sense,
that is, increasing the relative probability of beginning
a stereotyped pattern (Berridge and Aldridge, pages
194–204, this issue). SKF 38393 also produced sequen-
tial super-stereotypy in the second sense, boosting its
rate of syntactic completion to above normal levels
(Berridge and Aldridge, pages 194–204, this issue). By
contrast, neither a dopamine D2 agonist, quinpirole,
nor the peptide, ACTH-(1-24), enhanced the pattern,
and quinpirole actually reduced sequential stereotypy
(Berridge and Aldridge, pages 194–204, this issue).
The relationship between excessive grooming in-
duced by drug administration and the super-stereotypy
of this movement pattern remains to be understood.
Systemic SKF 38393 enhanced initiation and comple-
tion of the stereotyped pattern, but also increased the
amount of grooming behavior as has often been re-
ported (Deveney and Waddington, 1995, 1997; Downes
and Waddington, 1993; Eilam et al., 1992; Page and
Terry, 1997; Phillips et al., 1995; Starr and Starr, 1986;
Trampus et al., 1993; Wachtel et al., 1992; White et al.,
1988). Thus, it is conceivable that excessive grooming
is always accompanied by an increase in the stereotypy
of this sequential movement pattern. One of the goals
of this study was to find out whether or not that is true.
Another goal was to reconfirm whether D1 dopamine
receptors play a special role in sequential stereotypy.
Excessive grooming is also elicited by central admin-
istration of ACTH, CRF, oxytocin, bombesin, and other
peptides (Dunn, 1988; Dunn and Berridge, 1990; Dunn
et al., 1987; Flynn, 1991; Gispen et al., 1975; Isaacson
and Thomas, 1986; Kulkosky et al., 1988; Moody et al.,
1988; Piggins and Merali, 1992; Van Erp et al., 1993).
ACTH-elicited excessive grooming appears to be medi-
ated in part by dopamine systems (Cools et al., 1978,
1988; Dunn, 1988; Guild and Dunn, 1982; Spruijt et al.,
1986). ACTH causes dopamine release in the neostria-
tum (Florijn et al., 1993), and excessive grooming after
ACTH administration is reduced by dopamine antago-
nist administration (Cools et al., 1987, 1988; Guild and
Dunn, 1982; Isaacson et al., 1983), especially by D1
receptor antagonists (Van Wimersma Greidanus et al.,
1989) or antisense (Zhang et al., 1994). Thus, the mech-
anism of excessive grooming elicited by ACTH appears
to partly overlap with excessive grooming caused by
dopamine D1 agonists.
The ability of ACTH to increase grooming behavior
when administered centrally provides a means to test
whether all instances of excessive grooming that in-
volve dopamine systems necessarily also involve a con-
comitant increase in the strength of stereotyped se-
quences contained within the grooming. Or, stated
conversely, it allows us to test whether the amount of
grooming can be increased without increasing the rel-
ative probability or stereotypy of sequential patterns
within it.
This study examines the effects of intraventricular
administration of ACTH and of the dopamine D1 ago-
nists, SKF 38393 and SKF 89528, on grooming (Ber-




Sprague-Dawley male rats (n 5 12; 300–400 g) were
housed individually on a 14/10 hour light/dark cycle
throughout the experiment. All animal use procedures
were approved by the University of Michigan Unit for
Laboratory Animal Medicine and conformed to NIH
guidelines. Each rat was surgically implanted with
bilateral microinjection guide cannulae, one in the left
lateral ventricle and one in the right lateral ventricle.
Rats were anesthetized with ketamine (100 mg/kg, i.p.)
and xylazine (10 mg/kg, i.p) and treated with atropine
sulfate (3 mg/kg, i.p.) and bicillin (30,000 U i.m.). Ste-
reotaxic coordinates for cannulae implantation were:
AP 5 20.8, L5 6 3.5, and V 5 23.4 (each relative to
bregma). Each microinjection cannulae protruded 1
mm beyond the guide cannula. After surgery, each rat
received buprenorphine to alleviate discomfort during
postoperative recovery (0.8 mg/kg in 3 ml saline, i.p.).
Intraventricular microinjections, drugs,
and doses
Five minutes prior to each test session, rats received
bilateral microinjections (3 ml) of either vehicle or drug
(doses below) into the lateral ventricles. The dose was
always split equally across the left and right lateral
ventricles. Each rat was gently hand-held during its
microinjection. The microinjection was made at a con-
stant infusion rate over a 1-minute period. The micro-
injector remained in place for 30 seconds after the
infusion, then the contralateral microinjection was
made, the microinjector was removed, and the guide
cannulae caps were replaced. The administration order
of drugs, and of doses within each drug, was counter-
balanced across the rats.
Experiment 1 tested the intraventricular effects of
the same agents used in Experiment 1 of our periph-
eral administration study (Berridge and Aldridge,
pages 194–204, this issue). These were SKF 38393 (a
partial D1 agonist; doses 5 0 [vehicle], 5.0, 10, 15, 20
mg), quinpirole (a D2 agonist; doses 5 0 [vehicle], 5.0,
and 10 mg), and ACTH-(1-24) (doses 0 [vehicle] 2.0, 5.0,
and 10 mg). Doses were chosen from the literature on
intracranial microinjection of these agents (Bordi and
Meller, 1989; Cools et al., 1978; Delfs and Kelley, 1990;
Dunn, 1988; Gispen and Isaacson, 1981; Isaacson and
Thomas, 1986; Ranaldi and Beninger, 1994). The
broadest dose range was used for SKF 38393 because
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dopamine D1 receptors had been implicated in groom-
ing stereotypy by our peripheral administration study
(Berridge and Aldridge, pages 194–204, this issue),
and therefore was of the greatest interest here.
Behavioral testing and video analysis
Drugs were mixed fresh daily before each test. The
order of vehicle, drug, and dose administration was
balanced across rats. Behavioral tests were spaced 48
hours apart. For the purpose of statistical analysis,
trials in which only the control vehicle was adminis-
tered were combined together for each rat to produce a
single vehicle score.
All behavioral test procedures (other than the intra-
ventricular microinjection) were identical to those used
in our peripheral administration study (Berridge and
Aldridge, pages 194–204, this issue). Rats were habit-
uated to the microinjection and behavioral testing pro-
cedure for 4 consecutive days prior to the first drug
administration. Each rat was placed into a chamber
with a transparent floor, below which an angled mirror
reflected the image of the rat’s face and ventral surface
into the lens of a video camera, which was able to track
the movements of forepaws across the face. Videotapes
were later analyzed in slow motion (frame-by-frame to
1/10th actual speed, depending on the density of move-
ments) by trained observers who were blind to the
experimental condition of each rat, for (1) grooming
amount, (2) the relative probability that a syntactic
chain pattern would begin during grooming, and (3) the
proportion of completed syntactic chain patterns.
Grooming quantity
The quantity of grooming was measured as the num-
ber of seconds that a rat spent engaged in grooming
behavior (facial strokes, paw licking, body licking), and
was expressed as a percentage of the total observation
session.
Probability of pattern occurrence
(chain initiation)
A syntactic chain pattern contains 15–25 paw stroke
and licking movements arranged into 4 consecutive
phases. Phase I: 5 to 9 small, rapid forepaw strokes
around the nose made simultaneously and symmetri-
cally by both paws (“ellipses” because of their tight
elliptical trajectories), at a rate of at least 6 Hz. Phase
II: 1 to 4 small-to-medium strokes (up to the level of the
eye) made by only one paw at a time. Phase III: 3 to 10
large strokes (past the ear) made simultaneously by
both paws, often symmetrically. Phase IV: Rapid lat-
eral turn of the head towards a flank that initiates a
bout of body licking. Initiation of a syntactic chain was
considered to be the occurrence of Phase I followed
immediately by Phase II or Phase III. The relative
probability of chain initiation was calculated for each
rat as the frequency of chain initiations per minute
of grooming movements (chain initiation/minute of
grooming) (Berridge and Aldridge, pages 194–204, this
issue). Total grooming time includes both syntactic
chains and other grooming.
Pattern stereotypy (syntactic completion)
The best measure of pattern stereotypy is the prob-
ability that the pattern will be completed entirely, from
Phases I to IV. A completed pattern was considered to
be a grooming sequence in which Phase I was followed
immediately by subsequent phases leading to Phase III
and then Phase IV (Phase II is optional: most but not
all syntactic grooming chains include one). Phase IV
had to occur to within 5 seconds of the last Phase I
stroke. The degree or quality of stereotypy was calcu-
lated as the proportion of syntactic chains that, once
begun, were completed syntactically to Phase IV (Ber-
ridge and Aldridge, pages 194–204, this issue).
Histology
At the end of the experiment, rats were deeply anes-
thetized with sodium pentobarbital. In order to confirm
correct placement of the cannulae, 3 ml of ink was
injected into each side of the lateral ventricles. The rats
were perfused intracardially with saline, and the
brains were removed and inspected for the presence of
ink within both lateral ventricles.
Results
Grooming amount
The amount of time rats spent in grooming was sig-
nificantly altered by intraventricular drug administra-
tion (F(2,143) 5 13.81, P , 0.01; 2-way repeated-mea-
sures ANOVA, where drug type and dose were the
main factors; Fig. 1). Intraventricular ACTH microin-
jections increased the amount of grooming in propor-
tion to dose, more than doubling grooming amount at
the highest ACTH dose, which is consistent with many
earlier reports (F(3,47) 5 36.92, P , 0.01). Intraven-
tricular SKF 38393 microinjections did not change the
amount of grooming from vehicle control levels
(F(4,59) 5 2.14, n.s.). Quinpirole dramatically reduced
the proportion of time spent grooming at both doses
(F(2,35) 5 17.2, P , 0.01).
Initiation of syntactic chain sequences
The relative probability of beginning the sequential
pattern was altered by drug administration (F(2,
143) 5 17.2, P , 0.01; Fig. 2). The tendency to initiate
a syntactic chain pattern was increased only by SKF
38393, which at the highest doses nearly doubled the
relative probability of beginning a chain pattern during
grooming bouts (F(4,59) 5 11.4, P , 0.01). By contrast,
ACTH microinjections suppressed the relative proba-
bility of beginning the stereotyped pattern, especially
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at higher doses (F (3,47) 5 7.5, P , 0.05), even though
those had promoted the total amount of grooming.
Quinpirole microinjections also significantly sup-
pressed the initiation of syntactic chains in proportion
to dose (F(2,35) 5 6.48, P , 0.05).
Pattern stereotypy: syntactic completion
The likelihood of completing the movement pattern in a
fully stereotyped fashion, from Phase I through Phase IV,
was altered by drug administration (F2, 143) 5 15.73,
Fig. 1. Grooming amount (Experiment 1). Effects on time spent
grooming of intraventricular SKF 38393, quinpirole, and ACTH.
Amount of grooming is expressed as the percentage of time spent
grooming out of the entire observation period (symbolized by rat
engaged in grooming behavior). Dose 1: SKF 38393 5 5.0 mg, quinpi-
role 5 5.0 mg, and ACTH-(1-24) 5 2.0 mg. Dose 2: SKF 38393 5 10 mg,
quinpirole 5 10 mg, and ACTH 5 5.0. mg. Dose 3: SKF 38393 515 mg,
and ACTH 10mg. Dose 4: SKF 38393 5 20 mg. An asterisk denotes a
change from baseline level produced by a compound, statistically
significant at P , 0.05. Two asterisks denote a change from baseline
significant at P , 0.01.
Fig. 2. Pattern probability: syntactic chain initiation (Experiment
1). Effects on the relative probability of beginning a stereotyped
pattern of intraventricular SKF 38393, quinpirole, and ACTH. Rela-
tive probability is expressed as the rate of initiation of syntactic
chains per minute of grooming behavior (symbolized by choreograph
of first 3 phases of a syntactic grooming chain). Dose 1: SKF 38393 5
5.0 mg, quinpirole 5 5.0 mg, and ACTH-(1-24) 5 2.0 mg. Dose 2: SKF
38393 5 10 mg, quinpirole 5 10 mg, and ACTH 5 5.0. mg. Dose 3: SKF
38393 515 mg, and ACTH 10mg. Dose 4: SKF 38393 5 20 mg. Statis-
tical symbols as in Figure 1.
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P , 0.01; Fig. 3). After vehicle microinjections, rats com-
pleted approximately 80% of their stereotyped chain pat-
terns all the way to Phase IV (80.2 6 8%). This baseline
proportion of completed sequences was slightly lower
than found in most other studies (85 to 90%), perhaps
because of effects of the microinjection handling proce-
dure or because of the presence of the guide cannula
implant on the skull, which might have disrupted groom-
ing sequences. Neither SKF 38393 microinjections
(F(4,59) 5 0.72, n.s.) nor ACTH microinjections
(F(3,47) 5 0.97, n.s.) significantly altered the stereotypy
of this pattern in terms of the proportion of sequences
completed. However, quinpirole microinjections produced
a dramatic suppression of stereotypy, reducing the pro-
portion of syntactic chains that were completed in a ste-
reotyped fashion to below one-half of the baseline levels
at the highest dose (F(2,35 5 21.8, P , 0.01).
Discussion of experiment 1
ACTH elicited excessive grooming as expected when
administered intraventricularly. However, ACTH-in-
duced excessive grooming was not accompanied by an
increase in the relative probability or the pattern ste-
reotypy of the syntactic grooming sequence. On the
contrary, intraventricular ACTH diminished the rela-
tive probability of beginning the syntactic chain pat-
tern, and had no effect on the completion levels or
stereotypy of patterns that were begun. This indicates
that excessive grooming evoked by neuropharmacolog-
ical manipulations need not necessarily be accompa-
nied by enhancement of stereotyped sequential pat-
terns contained within the grooming.
Quinpirole, the dopamine D2 agonist, suppressed all
aspects of grooming. The amount of grooming, the rel-
ative probability of initiating a syntactic chain pattern
during the grooming that remained, and the likelihood
of completing the pattern in a stereotyped way if it
began, all were diminished after the D2 agonist. Each
of these effects were similar to those of peripheral
administration of quinpirole (Berridge and Aldridge,
pages 194–204, this issue).
Interestingly, intraventricular SKF 38393, the D1
agonist, increased the relative probability of beginning
a stereotyped sequential pattern, as it does when de-
livered peripherally (Berridge and Aldridge, pages
194–204, this issue). However, it left unchanged the
80% proportion of stereotyped chains that were com-
pleted syntactically all the way to Phase IV, although
when given peripherally in our earlier study it also
increased completion stereotypy (Berridge and Al-
dridge, pages 194–204, this issue). Further, although
SKF 38393 increased the probability of syntactic chain
patterns, it did not increase the total amount of groom-
ing movements at any of the doses tested. Taken to-
gether with the effect of ACTH, which increased the
amount of grooming without increasing completion ste-
reotypy, this represents a double dissociation between
the amount of grooming movements vs. the relative
probability of stereotyped movement patterns during
grooming.
It seemed possible that the doses of SKF 38393 used
in Experiment 1 were too low to increase grooming,
since they overlap with doses that have been microin-
jected directly into brain structures such as the neo-
Fig. 3. Pattern stereotypy: syntactic chain completion (Experi-
ment 1). Effects on the completion of syntactic chain patterns of
intraventricular SKF 38393, quinpirole, and ACTH. Syntactic com-
pletion is expressed as the percentage of grooming chains that were
fully completed through Phase IV, as a proportion of those that were
begun (symbolized by choreograph of completed syntactic grooming
chain). Dose 1: SKF 38393 5 5.0 mg, quinpirole 5 5.0 mg, and ACTH-
(1-24) 5 2.0 mg. Dose 2: SKF 38393 5 10 mg, quinpirole 5 10 mg, and
ACTH 5 5.0. mg. Dose 3: SKF 38393 515 mg, and ACTH 10mg. Dose
4: SKF 38393 5 20 mg. Statistical symbols as in Figure 1.
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striatum (Bordi and Meller, 1989; Delfs and Kelley,
1990; Ranaldi and Beninger, 1994). In order to test the
effects of higher doses, Experiment 2 re-examined the
effects of SKF 38393 on grooming amount and stereo-
typy using doses between 10–80 mg. ACTH was also
included in Experiment 2 at the dose that had most
effectively increased grooming amount in Experiment
1 (10 mg), in order to replicate whether ACTH-induced
excessive grooming occurs without increases in pattern
stereotypy. Finally, we compared the intraventricular
effects of SKF 82958, a full D1 agonist, which we pre-
viously had found to enhance pattern initiation when





Naive Sprague-Dawley male rats (n 5 24; 300–400 g)
were implanted with bilateral microinjection cannulae in
the lateral ventricles, and were tested using the same
procedure as in Experiment 1. Drugs and doses were:
SKF 38393 (0 [vehicle], 10, 20, 40, and 80 mg, i.c.v.);
ACTH-(1-24): (0 [vehicle], and 10 mg, i.c.v.); SKF 82958:
0 mg (vehicle), 5.0 and 10 mg (each dose split between the
two lateral ventricles). Twelve rats received all doses of
SKF 38393 and of ACTH, and 12 rats received all doses of
SKF 82958, in counter-balanced order.
Results
Amount of grooming
ACTH again increased the amount of grooming to
more than 200% the vehicle control level (F(5,71) 5
22.7, P , 0.01; post hoc paired-comparison tests of
ACTH to vehicle, Bonferroni P , 0.05, Fig. 4). By
contrast, SKF 38393 microinjections reduced the pro-
portion of time spent grooming, roughly in proportion
to dose (F(4, 59) 5 18.6, P , 0.01). At the 80-mg dose,
the highest dose tested, the amount of grooming was
only 25% of the vehicle control level (P , 0.05, Bonfer-
roni). SKF 82958, the full D1 agonist, significantly
increased the amount of time rats spent in grooming
(F(2,35) 5 6.67, P , 0.01). The amount of grooming was
raised after SKF 82958 to approximately 150% of the
vehicle control level by both the 5 mg dose and the 10 mg
dose (each dose compared to control level, P , 0.05,
Bonferroni).
Initiation of syntactic chain sequence pattern
SKF 38393 again increased the probability of begin-
ning a stereotyped movement pattern in a dose-depen-
dent fashion (F(4,59) 5 5.52, P , 0.01; Fig. 5). SKF
82958 also increased the relative probability of initiat-
ing a syntactic chain pattern (F(2,35) 5 15.92, P ,
0.001), just as SKF 38393 did. At the 80-mg dose of SKF
38393, and at the 5- and 10-mg doses of SKF 89528, the
relative probability of initiating a chain was more than
200% of the vehicle control level (P , 0.05 each, Bon-
ferroni). By contrast, ACTH again reduced the ten-
dency to initiate the stereotyped movement pattern
(P , 0.05, Bonferroni).
Pattern stereotypy: syntactic completion
On vehicle control trials, rats in this experiment
completed approximately 70% of their syntactic chains
Fig. 4. Grooming amount (Experiment 2). Effects on time spent
grooming of intraventricular SKF 38393, quinpirole, and ACTH.
Amount of grooming is expressed as the percentage of time spent
grooming out of the entire observation period (symbolized by rat
engaged in grooming behavior). Dose 1: SKF 38393 5 10 mg, SKF
82958 5 5.0 mg, and ACTH-(1-24) 5 10 mg. Dose 2: SKF 38393 5 20
mg, and SKF 829585 10 mg. Dose 3: SKF 38393 540 mg, and Dose 4:
SKF 38393 5 80 mg. Statistical symbols as in Figure 1.
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to Phase IV (Fig. 6). This again is a lower baseline level
of stereotypy than seen in most earlier studies, and
may be related to the intraventricular administration
procedure or the presence of cannulae implants on the
head. ACTH did not alter this control level of stereo-
typy, just as it failed to do so in Experiment 1. SKF
38393, at the lower doses (used also in Experiment 1),
also did not alter the level of pattern stereotypy. SKF
38393 at the highest two doses actually suppressed
pattern completion to about one-half the vehicle control
level ((F(5,71) 5 7.01, P , 0.01; P , 0.05 each for the 2
highest doses, Bonferroni).
By contrast, SKF 82959, the full D1 agonist, en-
hanced syntactic completion or sequential stereotypy of
the pattern (F(2,35) 5 4.23, P , 0.05). The proportion
of completely stereotyped patterns rose from about 70
to 84% of syntactic chains after 5 mg SKF 82958, and to
86% after 10 mg SKF 82958 (P , 0.05, Bonferroni).
GENERAL DISCUSSION
The results of these intraventricular microinjection
experiments confirm that dopamine D1 receptors play
a special role in controlling the stereotypy of a complex
sequential pattern of movements. Both SKF 38393 and
SKF 82958 increased the relative probability that the
syntactic grooming chain would begin during a groom-
ing bout. Additionally, the full D1 agonist SKF 82958
produced sequential super-stereotypy of the pattern
itself, making rats even more likely than normal to
complete all 4 phases in syntactic order.
Neither quinpirole, a D2 dopamine agonist, nor ACTH-
(-24) increased the relative probability or the stereotypy
of the movement pattern, even though ACTH (like SKF
82958) produced excessive grooming. Both quinpirole and
ACTH instead suppressed the relative probability of be-
ginning the complex stereotyped movement pattern, and
either suppressed or had no effect on pattern stereotypy
or completion. These results clearly indicate that control
of the amount of grooming behavior can be decoupled
from control of stereotypy of sequential patterns within
grooming. Intraventricular ACTH increased grooming
movements, but decreased the probability of engaging in
a syntactic chain pattern, whereas SKF 38393 increased
the probability of the stereotyped movement pattern, but
decreased the amount of grooming movements. This dou-
ble dissociation demonstrates that sequential stereotypy
is not a necessary concomitant of excessive grooming.
Comparison to peripheral administration:
amount of grooming
ACTH is well known to produce excessive grooming
only when it is given centrally, and not when given
peripherally (Dunn, 1988; Gispen and Isaacson, 1981).
However, the opposite now appears to be true for SKF
38393. Peripheral administration of that partial D1
agonist robustly increases grooming amount (Fletcher
and Starr, 1987; Page and Terry, 1997; Starr and
Starr, 1986; White et al., 1988), and also increases
completion of the stereotyped movement pattern (Ber-
ridge and Aldridge, pages 194–204, this issue). Our
Fig. 5. Pattern probability: syntactic chain initiation (Experiment
2). Effects on the relative probability of beginning a stereotyped
pattern of intraventricular SKF 38393, quinpirole, and ACTH. Rela-
tive probability is expressed as the rate of initiation of syntactic
chains per minute of grooming behavior (symbolized by choreograph
of first 3 phases of a syntactic grooming chain). Dose 1: SKF 38393 5
10 mg, SKF 82958 5 5.0 mg, and ACTH-(1-24) 5 10 mg. Dose 2: SKF
38393 5 20 mg, and SKF 829585 10 mg. Dose 3: SKF 38393 540 mg,
and Dose 4: SKF 38393 5 80 mg. Statistical symbols as in Figure 1.
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present results indicate that SKF 38393 fails to pro-
duce excessive grooming when it is administered intra-
ventricularly. We note there are a few reports of in-
creased grooming produced by central administration
of SKF 38393 (Fletcher and Starr, 1987; Hartgraves
and Randall, 1986). However, those studies have gen-
erally described animals that received 6-hydroxydopa-
mine lesions prior to receiving the drug, which would
result in dopamine-denervation and receptor supersen-
sitivity (Fletcher and Starr, 1987; Hartgraves and Ran-
dall, 1986). Prior dopamine lesions may be needed for
the elicitation of excessive grooming by central SKF
38393. To our knowledge, excessive grooming elicited
by central administration of SKF 38393 has not been
reported in normal rats (Bordi and Meller, 1989; Phil-
lips et al., 1995), so our finding that intraventricular
SKF 38393 fails to promote the amount of grooming
(and actually suppresses grooming at high doses) may
not contradict published results.
By contrast, SKF 82958, a full D1 agonist, did pro-
duce excessive grooming after intraventricular admin-
istration in normal rats. We believe this may be the
first report of excessive grooming induced by central
administration of a D1 dopamine agonist in normal
animals. Interestingly, SKF 82958 did not produce ex-
cessive grooming after systemic administration in a
companion study (Berridge and Aldridge, pages 194–
204, this issue), providing another central vs. periph-
eral difference.
It is not clear why the amount of grooming should
be affected differently by a D1 dopamine agonist
after central vs. peripheral administration. One pos-
sible factor that could influence the differences be-
tween central vs. peripheral administration may be
differential diffusion to the diverse brain regions
relevant to these behavioral effects. For example, the
relative distribution of the drug between ventral and
dorsal striatum might be important to the effects on
grooming amount and stereotypy (Cromwell and Ber-
ridge, 1996; Dickson et al., 1994; Fletcher and Starr,
1987; Neisewander et al., 1995). Peripheral agents
must reach targets through the blood supply, receiv-
ing general distribution across neuroanatomical
sites. Micro-injection into the cerebral ventricles, by
comparison, provides intense and direct stimulation
of structures adjacent to the ventricles, but relatively
less stimulation to more distal structures. Another
factor might be interaction between D1 and D2 fam-
ilies of receptor subtypes. Each drug produces a dif-
ferent pattern of activation across these subtypes.
SKF 38393 is only a partial D1 agonist, achieving
less adenylate cyclase activity than dopamine itself,
whereas SKF 82958 is a full D1 agonist (Mottola et
al., 1996). In addition, SKF 82958 has been sug-
gested to have effects on D2 autoreceptors (Ruskin et
al., 1998). Although D2 receptor activation by quin-
pirole does not enhance grooming, there have been
suggestions that the effects of D2 receptor activation
may be gated by simultaneous D1 activation (Bordi
and Meller, 1989; Wachtel et al., 1989; White et al.,
1988; Wirtshafter and Krebs, 1997), and the possi-
bility of receptor subtype interaction regarding
grooming deserves exploration.
Fig. 6. Pattern stereotypy: syntactic chain completion (Experi-
ment 2). Effects on the completion of syntactic chain patterns of
intraventricular SKF 38393, quinpirole, and ACTH. Syntactic com-
pletion is expressed as the percentage of grooming chains that were
fully completed through Phase IV, as a proportion of those that were
begun (symbolized by choreograph of completed syntactic grooming
chain). Dose 1: SKF 38393 5 10 mg, SKF 82958 5 5.0 mg, and
ACTH-(1-24) 5 10 mg. Dose 2: SKF 38393 5 20 mg, and SKF 82958 5
10 mg. Dose 3: SKF 38393 540 mg, and Dose 4: SKF 38393 5 80 mg.
Statistical symbols as in Figure 1.
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Comparison to peripheral administration:
sequential stereotypy of grooming
The sequential stereotypy of grooming has now been
demonstrated to be enhanced by both peripheral and
intra-ventricular administration of D1 agonists. The
relative probability of initiating a syntactic grooming
chain pattern was always enhanced by D1 agonist ad-
ministration, regardless of whether of SKF 38393 or
SKF 89258 was given, and regardless of whether the
route of administration was central or peripheral (Ber-
ridge and Aldridge, pages 194–204, this issue). Super-
stereotypy of pattern completion, however, depended
on the route of administration. In this study, super-
stereotypy of pattern completion was produced only by
intraventricular SKF 82958. By contrast, only SKF
38393 produced super-stereotypy of pattern completion
after peripheral administration. The same interactions
involving differential diffusion to neuroanatomical tar-
gets, or degree of D1 vs. D2 receptor subtype activation,
that are relevant to excessive grooming may also apply
to the effect of route of administration on stereotypy of
syntactic pattern completion.
Role of neostriatum and mesostriatal dopamine
projections in pattern stereotypy
Relevant to our conclusion that D1 dopamine recep-
tors mediate sequential super-stereotypy, a previous
study found that mutant mice lacking dopamine D1-A
receptors have deficits in the stereotypy of their syn-
tactic chains of grooming movements (Cromwell et al.,
1998). The stereotyped pattern of syntactic grooming
chains is also disrupted in mice by the Weaver gene
mutation that alters the nigrostriatal dopamine sys-
tem (Bolivar et al., 1996; Coscia and Fentress, 1993),
and is disrupted in rats by 6-OHDA lesions of the
substantia nigra in rats, which destroy dopamine pro-
jections to the neostriatum (Berridge, 1989), as well as
by excitotoxin lesions or ablation of the neostriatum
itself (Berridge and Fentress, 1987; Berridge and
Whishaw, 1992; Cromwell and Berridge, 1996). Thus,
the nigrostriatal system appears to be crucial to control
this sequential pattern.
Electrophysiological studies by Aldridge and col-
leagues have identified a neuronal basis in the neostri-
atum that may mediate this stereotyped movement
pattern (Aldridge and Berridge, 1998; Aldridge et al.,
1993). In one study, approximately 40% of neostriatal
neurons coded a sequential aspect of the movement
pattern, compared to only 14% that coded motor as-
pects of component movements (Aldridge and Berridge,
1998). Neurons that responded to sequential aspects of
the stereotyped movement pattern were distributed
anatomically throughout the neostriatum, but coding
of the pattern appeared to be especially strong for
neurons in the anterior dorsolateral region of the neo-
striatum. In the dorsolateral neostriatum, neurons in-
creased activity by over 100% during this stereotyped
movement pattern, compared to only 30% by neostria-
tal neurons elsewhere (Aldridge and Berridge, 1998).
In addition, dorsolateral neostriatal neurons were
more likely than other neurons to code multiple se-
quential phases of the pattern most relevant to com-
pletion or pattern stereotypy (since terminal phases
are what completed patterns have, and what incom-
plete patterns lack) (Aldridge and Berridge, 1998). The
hypothesis that the sequential stereotypy of behavior
might be mediated by particular neostriatal neurons is
compatible with recent computer models suggesting
that the sequencing of behavior might be controlled as
a specific function by a dedicated population of basal
ganglia neurons (Berns and Sejnowski, 1998).
Clinical implications
Super-stereotypy of complex behavioral sequences is
a feature of several human disorders, such as
Tourette’s syndrome and obsessive-compulsive disor-
der (Rapoport and Wise, 1988; Toates, 1990). It is
widely believed that mesostriatal dopamine systems
may be involved in the generation of these complex
stereotypies of movement and thought (Goodman et al.,
1990; Hollander et al., 1989; McDougle, 1997; Rap-
oport, 1994; Ridley, 1994). Specifically, hyperactivity in
dopamine systems (coupled with dysfunction of seroto-
nin systems) has been suggested by many investigators
to be involved in stereotypy disorders, based on the
logic that dopamine antagonists (combined with other
agents) are helpful in treating the stereotypies of some
patients (Goodman et al., 1990; McDougle, 1997;
McDougle et al., 1993). Other evidence comes from
observations of the induction of human stereotypies by
drugs that promote dopamine neurotransmission. For
example, cocaine has been reported to worsen the
symptoms of Tourette’s syndrome (Cardoso and Jank-
ovic, 1993). Similarly, the removal of long-term cloza-
pine treatment, after dopamine receptor upregulation,
results in tics and in obsessive-compulsive symptoms
in some patients (Poyurovksy et al., 1998). However,
the role of particular dopamine receptor subtypes re-
mains unclear in the behavioral stereotypies of
Tourette’s or obsessive-compulsive disorder. Although
a link to D2 receptors has been suggested for such
disorders (Comings et al., 1991), other studies have
rejected such a link (Gelernter et al., 1990, 1994). Neg-
ative results have similarly been reported for links
between obsessive-compulsive disorder or Tourette’s
syndrome and the specific dopamine D3 receptor (Cata-
lano et al., 1994), D4 receptor (Barr et al., 1996), and D5
receptor subtypes (Barr et al., 1997). Negative results
of a few studies do not conclusively rule out a role for
these receptor subtypes, of course, but they indicate
that the relation of pathological sequential stereotypy
to a receptor subtype remains opaque.
Our own results suggest the possibility of a special
role for the D1 family of dopamine receptor subtypes
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since only the D1 agonists, SKF 38393 and SKF 89258,
produced super-stereotypy of the complex movement
pattern studied here after intraventricular or periph-
eral administration (Berridge and Aldridge, pages
194–204, this issue). Still, it must be acknowledged
that the role of D1 receptors in human clinical condi-
tions is no more clear than the others. For example,
SKF 38393 has been reported not to worsen the symp-
toms of Tourette’s syndrome (Braun et al., 1989). But
Tourette’s patients may contain multiple subgroups of
individuals who respond differently to drug adminis-
tration (Petter et al., 1998). The role of D1 activation in
human patients with sequential super-stereotypy may
be worth closer examination.
Conclusion
The results of these experiments, and of our compan-
ion study (Berridge and Aldridge, pages 194–204, this
issue), indicate a special role for central dopamine D1
receptors in the sequential stereotypy of behavior. Only
D1 agonists appear to produce super-stereotypy of the
sequential pattern of syntactic grooming chains. Nei-
ther a D2 agonist nor ACTH increased stereotypy of the
pattern, regardless of whether they increased groom-
ing movements. Our results thus highlight a potential
role for D1 dopamine receptors, probably within the
basal ganglia, in the production of sequential super-
stereotypy of complex behavioral patterns.
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